30 January 2023 - Biopharmaceutical company Xeris Biopharma Holdings Inc (Nasdaq: XERS) announced on Monday that the US Food and Drug Administration (FDA) has granted its subsidiary Xeris Pharmaceuticals Inc orphan-drug exclusivity for Recorlev (levo...
30 January 2023 - Drug discovery company Charles River Laboratories International Inc (NYSE: CRL) disclosed on Monday that it has acquired the remaining 80% ownership stake in SAMDI Tech Inc, a provider of screening (HTS) solutions for drug discovery...
30 January 2023 - Alpha Biopharma, a China-based developer of innovative drugs, announced on Sunday that the company's New Drug Application (NDA) for Zorifertinib, a next-generation EGFR-TKI, has been accepted by the Centre for Drug Evaluation (...
30 January 2023 - Asep Medical Holdings Inc. (CSE: ASEP) (OTCQB: SEPSF), a Canada-based company dedicated to addressing antibiotic failure by developing novel solutions for significant unmet medical needs, announced on Friday that it entered into a j...
30 January 2023 - InDex Pharmaceuticals Holding AB (publ), a Sweden-based pharmaceutical development company focusing on immunological diseases where there is a high unmet medical need for new treatment options, announced on Friday an update in the t...